206 related items for PubMed ID: 9105061
1. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
Weersink EJ, Douma RR, Postma DS, Koëter GH.
Am J Respir Crit Care Med; 1997 Apr; 155(4):1241-6. PubMed ID: 9105061
[Abstract] [Full Text] [Related]
2. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
Noonan MJ, Chervinsky P, Wolfe J, Liddle R, Kellerman DJ, Crescenzi KL.
J Asthma; 1998 Apr; 35(2):153-64. PubMed ID: 9576141
[Abstract] [Full Text] [Related]
3. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[Abstract] [Full Text] [Related]
4. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[Abstract] [Full Text] [Related]
5. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
6. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.
Weersink EJ, van Zomeren EH, Koëter GH, Postma DS.
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1144-50. PubMed ID: 9351614
[Abstract] [Full Text] [Related]
7. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[Abstract] [Full Text] [Related]
8. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M, Zachgo W, von Berg A, Kamin W, Stern-Sträter C, Steinkamp G, VIAPAED Study Group.
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[Abstract] [Full Text] [Related]
9. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
10. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP, Stenback S, Lipworth BJ.
Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
[Abstract] [Full Text] [Related]
11. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH, Worsdell M, Barnes PJ.
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[Abstract] [Full Text] [Related]
12. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[Abstract] [Full Text] [Related]
13. Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
Matz J, Emmett A, Rickard K, Kalberg C.
J Allergy Clin Immunol; 2001 May; 107(5):783-9. PubMed ID: 11344343
[Abstract] [Full Text] [Related]
14. Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate.
Lindqvist A, Karjalainen EM, Laitinen LA, Kava T, Altraja A, Pulkkinen M, Halme M, Laitinen A.
J Allergy Clin Immunol; 2003 Jul; 112(1):23-8. PubMed ID: 12847475
[Abstract] [Full Text] [Related]
15. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
[Abstract] [Full Text] [Related]
16. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
Visser MJ, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL.
Am J Respir Crit Care Med; 2001 Dec 01; 164(11):2073-7. PubMed ID: 11739137
[Abstract] [Full Text] [Related]
17. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T.
Am J Respir Crit Care Med; 2000 Feb 01; 161(2 Pt 1):527-34. PubMed ID: 10673196
[Abstract] [Full Text] [Related]
18. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I, Woodcock A, Parker D, Rice L, SOLTA study group.
Respir Res; 2007 Sep 27; 8(1):67. PubMed ID: 17897478
[Abstract] [Full Text] [Related]
19. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
de Blic J, Ogorodova L, Klink R, Sidorenko I, Valiulis A, Hofman J, Bennedbaek O, Anderton S, Attali V, Desfougeres JL, Poterre M.
Pediatr Allergy Immunol; 2009 Dec 27; 20(8):763-71. PubMed ID: 19239660
[Abstract] [Full Text] [Related]
20. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
Br J Clin Pharmacol; 2004 Jul 27; 58(1):26-33. PubMed ID: 15206989
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
